Kelly Lowe

Kelly Lowe serves as a key procurement lead within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical responses to emerging infectious, immunologic, and allergic threats. She manages complex acquisitions for high-containment laboratory infrastructure, diagnostic tools, and specialized analytical instrumentation critical to biosafety and biocontainment operations. Her work ensures timely delivery of mission-critical capabilities through competitive contracting processes aligned with federal acquisition regulations, with a strong emphasis on technical precision and regulatory compliance in high-risk scientific environments. Lowe maintains consistent relationships with specialized contractors including Quality Biological, Inc. and Genomic Labs Ltd., firms renowned for their expertise in biosafety-grade reagents, genomic sequencing systems, and high-containment laboratory support services. Her procurement approach favors established vendors with proven track records in handling biohazardous materials and maintaining stringent quality control standards, reflecting NIAID’s need for reliability in mission-critical supply chains. She engages these partners through long-term, performance-based contracts that prioritize technical validation and regulatory alignment. Her contracting portfolio reflects a strong preference for open competition, with 80% of acquisitions conducted without set-asides, while maintaining a deliberate 20% commitment to total small business set-asides under FAR 19.5. This balance ensures access to specialized capabilities while actively fostering participation from small businesses capable of meeting NIAID’s rigorous scientific and operational demands. Lowe’s primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing), supporting the acquisition of advanced mass spectrometers, PCR platforms, and biosafety cabinet systems. She also regularly procures maintenance and calibration services under NAICS 811210 and 811310, ensuring continuous operability of precision equipment. Her technical domain expertise spans biosafety Level 3 and 4 laboratory infrastructure, diagnostic assay development, and high-throughput genomic analysis systems, making her a vital link between scientific requirements and compliant, effective procurement execution.